Structure (51662 1685 Structure)
Verapamil Hydrochloride Injection, Solution
Product Images NDC 51662-1686
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 51662-1686). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Table (51662 1685 Table 1)
This text provides a suggested treatment plan for acute cardiovascular adverse reactions. It includes information on specific adverse reactions such as symptomatic hypotension, bradycardia, AV block, and rapid ventricular rate, along with proven effective treatments and supportive measures. The listed treatments include medications like Dopamine, Isoproterenol HCI, and Norepinephrine bitartrate, as well as procedures like DC-cardioversion and cardiac pacing. Supportive treatments such as intravenous fluids and Trendelenburg positioning are also recommended. The text emphasizes the importance of prompt and appropriate management of these adverse reactions, even though experience with treatment has been limited due to the low frequency of such events.*
Label (51662 1686 1 Rfid)
This is a product label with a unique identification number and contact information for the manufacturer. The label also specifies that the product is prescription-only. Please note that specific details about the product are not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
